NS
Article DetailSEC EDGAR Filings
SEC EDGAR Filings

8-K - Glucotrack, Inc. - 1.01 / 2.03 / 3.02 / 9.01

Filed: 2026-04-14 AccNo: 0001493152-26-016507 Size: 265 KB Item 1.01: Entry into a Material Definitive Agreement Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Item 3.02: Unregistered Sales of Equity Securities Item 9.01: Financial Statements and Exhibits
发布时间04/14 16:15 UTC
首次发现04/14 16:16 UTC
热度106.8
重要度78
情绪-0.04

站内整理正文

优先显示结构化正文;如果正文还未抽出,则回退到摘要。
sec_edgar_index_v1 · 936 字符

Form 8-K - Current report: SEC Accession No. 0001493152-26-016507

Filing Date: 2026-04-14

Accepted: 2026-04-14 12:15:07

Documents: 12

Period of Report: 2026-04-14

Items: Item 1.01: Entry into a Material Definitive Agreement Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Item 3.02: Unregistered Sales of Equity Securities Item 9.01: Financial Statements and Exhibits

Glucotrack, Inc. (Filer) CIK : 0001506983 (see all company filings) EIN. : 980668934 | State of Incorp.: DE | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-41141 | Film No.: 26859926 SIC : 3841 Surgical & Medical Instruments & Apparatus (CF Office: 08 Industrial Applications and Services)

1 | 8-K | form8-k.htm iXBRL | 8-K

2 | EX-10.1 | ex10-1.htm | EX-10.1

3 | XBRL SCHEMA FILE | gctk-20260414.xsd | EX-101.SCH

4 | XBRL LABEL FILE | gctk-20260414_lab.xml | EX-101.LAB